Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M817Revenue $M144Net Margin (%)9.7Altman Z-Score7.6
Enterprise Value $M762EPS $0.3Operating Margin %12.2Piotroski F-Score4
P/E(ttm)63.6Beneish M-Score-1.9Pre-tax Margin (%)10.4Higher ROA y-yN
Price/Book6.810-y EBITDA Growth Rate %--Quick Ratio1.7Cash flow > EarningsY
Price/Sales5.75-y EBITDA Growth Rate %--Current Ratio1.9Lower Leverage y-yY
Price/Free Cash Flow28.4y-y EBITDA Growth Rate %-26.7ROA % (ttm)8.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)14.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M49.4ROIC % (ttm)35.7Gross Margin Increase y-yN

Gurus Latest Trades with SUPN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SUPNRobert Bruce 2015-12-31 Reduce-0.57%$12.78 - $18.86
($15.48)
$ 16.547%Reduce -35.48%254,581
SUPNJoel Greenblatt 2015-12-31 Reduce$12.78 - $18.86
($15.48)
$ 16.547%Reduce -13.63%33,808
SUPNRobert Bruce 2015-09-30 Reduce-1.5%$13.62 - $21.26
($18.58)
$ 16.54-11%Reduce -43.19%394,581
SUPNJoel Greenblatt 2015-09-30 Reduce-0.01%$13.62 - $21.26
($18.58)
$ 16.54-11%Reduce -55.66%39,142
SUPNGeorge Soros 2015-06-30 Sold Out -0.01%$12.09 - $18.37
($14.2)
$ 16.5416%Sold Out0
SUPNJoel Greenblatt 2015-06-30 Add0.01%$12.09 - $18.37
($14.2)
$ 16.5416%Add 111.74%88,267
SUPNGeorge Soros 2015-03-31 Buy 0.01%$8.18 - $12.09
($9.45)
$ 16.5475%New holding107,308
SUPNJoel Greenblatt 2015-03-31 Buy $8.18 - $12.09
($9.45)
$ 16.5475%New holding41,686
SUPNRobert Bruce 2014-12-31 Add0.68%$7.49 - $9.49
($8.4)
$ 16.5497%Add 73.65%694,581
SUPNRobert Bruce 2014-09-30 Add0.73%$7.99 - $11.13
($8.98)
$ 16.5484%Add 300.00%400,000
SUPNRobert Bruce 2014-06-30 Buy 0.25%$7.32 - $10.85
($8.88)
$ 16.5486%New holding100,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SUPN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SUPN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Bhatt Padmanabh P.Sr. VP of IP, CSO 2016-04-11Sell30,762$16.490.3view
Bhatt Padmanabh P.Sr. VP of IP, CSO 2015-12-09Sell14,238$14.911.01view
BARRETT M JAMESDirector 2015-12-08Sell212,970$14.5613.6view
BARRETT M JAMESDirector 2015-11-25Sell16,179$16.351.16view
BARRETT M JAMESDirector 2015-11-18Sell93,000$16.61-0.42view
BARRETT M JAMESDirector 2015-11-16Sell119,650$16.241.85view
Bhatt Padmanabh P.Sr. VP of IP, CSO 2015-11-04Sell5,000$19.9-16.88view
Schwabe Stefan K.F.Executive Vice President R&D 2015-07-28Sell2,350$21.2-21.98view
PATRICK GREGORY SVP, CFO 2015-07-16Sell6,217$20-17.3view
Schwabe Stefan K.F.Executive Vice President R&D 2015-07-13Sell1,950$19.23-13.99view

Quarterly/Annual Reports about SUPN:

News about SUPN:

Articles On GuruFocus.com
Robert Bruce new Buys Feb 16 2015 
Third Quarter Was Robert Bruce's Busiest in 2014 Nov 21 2014 
Supernus Pharmaceuticals Reports Insider Buys Mar 26 2013 

More From Other Websites
Supernus Announces First Quarter 2016 Financial Results May 03 2016
5:02 pm Supernus Pharma misses by $0.01, misses on revs; reaffirms FY16 revs guidance May 03 2016
Supernus Announces First Quarter 2016 Financial Results May 03 2016
Q1 2016 Supernus Pharmaceuticals Inc Earnings Release - After Market Close May 03 2016
SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Apr 19 2016
Supernus to Host First Quarter 2016 Earnings Conference Call Apr 19 2016
Supernus to Host First Quarter 2016 Earnings Conference Call Apr 19 2016
ETF’s with exposure to Supernus Pharmaceuticals, Inc. : April 19, 2016 Apr 19 2016
ETF’s with exposure to Supernus Pharmaceuticals, Inc. : April 8, 2016 Apr 07 2016
Supernus Pharmaceuticals, Inc. :SUPN-US: Earnings Analysis: 2015 By the Numbers Apr 06 2016
United Therapeutics, Supernus sue PTO over patent Apr 01 2016
6 stocks to watch Mar 31 2016
SUPERNUS PHARMACEUTICALS INC Financials Mar 12 2016
SUPERNUS PHARMACEUTICALS INC Files SEC form 10-K, Annual Report Mar 09 2016
SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers,... Mar 04 2016
Edited Transcript of SUPN earnings conference call or presentation 3-Mar-16 2:00pm GMT Mar 03 2016
Supernus Pharmaceuticals Inc Earnings Call scheduled for 9:00 am ET today Mar 03 2016
SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Mar 03 2016
Supernus tops 4Q profit forecasts Mar 02 2016
Supernus tops 4Q profit forecasts Mar 02 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)